Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The function of
FAM9C
encoding a testis-exclusively expressed and nuclear-localized protein remains unknown. In the present study, we evaluated the role of
FAM9C
in human
hepatocellular carcinoma
. We found that among three FAM9 family members, only
FAM9C
was frequently upregulated in
HCC
specimens compared with that in corresponding adjacent non-cancer liver tissues.
FAM9C
was located in the nucleus of
HCC
cells, as shown by both western blotting and immumofluorescence assays. Significantly,
FAM9C
overexpression promoted proliferation, clonogenicity in an anchorage-dependent manner, in vivo tumorigenicity of YY-8103, and Huh-7 cells. In contrast,
FAM9C
knockdown suppressed proliferation, anchorage-dependent colony formation and in vivo tumorigenicity of QGY-7703, and BEL-7404 cells. However,
FAM9C
had no significant effects on cell cycle progression when
FAM9C
was stably overexpressed in Huh-7 cells or knocked down in BEL-7404 cells. Most importantly,
FAM9C
regulated activation of Akt and UV-induced apoptosis in
HCC
cells.
FAM9C
overexpression increased the phosphorylation levels of Akt and anti-apoptotic ability of Huh-7 cells, whereas endogenous
FAM9C
knockdown reduced the phosphorylated levels of Akt and anti-apoptotic ability of BEL-7404 cells. Furthermore, the anti-apoptotic function of
FAM9C
could be prevented when the PI3K-Akt pathway was in a loss-of-function caused by RNA interference against Akt or PI3K inhibitor LY294002 in
HCC
cells. Taken together, our data demonstrate that
FAM9C
as a novel cancer testis gene plays an anti-apoptotic role in human
hepatocellular carcinoma
through activating the PI3K/Akt signaling pathway, and serves as a promising target for
HCC
therapy.
...
PMID:FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. 2383 95